Arrests made in counterfeiting of GSK's weight-loss drug, Alli; FDA guidance covers numerical IDs for drug packaging;

> The Justice Department has made two arrests in the recent counterfeiting of Alli, the weight-loss drug from GSK. Article

> The FDA has issued final guidance, Standards for Securing the Drug Supply Chain--Standardized Numerical Identification for Prescription Drug Packages. Guidance

> Despite all the research muscle applied to personalized medicine, little is happening with process development and manufacturing. Article

> State drug regulators in India are on a GMP-violation tear, canceling the licenses of 274 manufacturing units in Maharashtra, 71 units in Mumbai, and 120 in Konkan, among others. Article (subscription required)

> Texas A&M University System is beginning construction on a flexible-by-design therapeutics manufacturing facility for rapid and scalable production of clinical trial supplies. Article

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.